In case the dose of your concomitant CYP3A4 inducer cannot be decreased or discontinued, implant elimination can be vital and the affected person need to then be dealt with which has a buprenorphine dosage variety that allows dose adjustments. If a CYP3A4 inducer is discontinued in a affected person